synthetic peptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-01-01 and is reviewed periodically as new material appears.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
=== Isometric activity === In 1993, isometric exercise training was applied for four weeks resulting in isometric peak power at 60% of maximal voluntary contraction. The increase in isometric power was later shown to have no significant effect on serum creatine kinase (CK) after two weeks of strength training.
The commission's President (as of 2021 Ursula von der Leyen) sets the agenda for its work. Decisions are taken by a simple majority vote, often through a "written procedure" of circulating the proposal and adopting it if there are no objections. In response to Ireland's initial rejection of the Treaty of Lisbon, it was agreed to keep the system of one Commissioner from each of the member states, including the President and the High Representative for Foreign and Security Policy (currently Josep Borrell) The Commissioner President is elected by the European Parliament by an absolute majority of its members, following the parliamentary elections every five years, on the basis of a proposal by the European Council. The latter must take account of the results of the European elections, in which European political parties announce the name of their candidate for this post. Hence, in 2014, Juncker, the candidate of the European People's Party which won the most seats in Parliament, was proposed and elected. The remaining commissioners are appointed by agreement between the president-elect and each national government, and are then, as a block, subject to a qualified majority vote of the council to approve, and majority approval of the Parliament. The Parliament can only approve or reject the whole commission, not individual commissioners but conducts public hearings with each of them prior to its vote, which in practice often triggers changes to individual appointments or portfolios.
==== Gastrointestinal tract ==== Secondary consequences of uremia on the gastrointestinal tract in cats are mainly fibrosis and mineralization of the gastric mucosa, but no gastric ulcers, so that the gastric acid blockers such as omeprazole, which have long been recommended for therapy, are no longer indicated. Mirtazapine has been shown to stimulate the appetite and reduce uraemic nausea.
Sources: en.wikipedia.org
== Personal life == Yates lives in Marbella with his wife, Brazilian fitness model Glauce "Gal" Ferreira, whom he had met at the 2008 Arnold Classic. His son with his ex-wife Deb is also a bodybuilder and the two work closely together. Yates practises yoga every day and has described yoga and meditation as life-altering experiences. He has endorsed the use of psychedelics such as ayahuasca for religious and spiritual purposes. He is open about his cannabis use, which predates his bodybuilding career; in a July 2017 appearance on The Joe Rogan Experience, he stated that cannabis has "anti-cancer" properties and said that he is an advocate for its legalisation for this reason in addition to its relaxing properties and temporary increases in respiratory capacity. Yates revealed his belief in Holocaust denial theories whilst being interviewed by Dave Palumbo in April 2018, claiming that the Holocaust death toll had been "exaggerated" and that two forensic studies (which he did not provide the names of) had concluded that no gas was ever used at the Auschwitz concentration camp.
NOS Journaal, a radio news bulletin that is broadcast every hour on the public broadcasting channels NPO Radio 1, NPO Radio 2, NPO Radio 4 and NPO Radio 5. NOS Headlines, a radio news bulletin especially made for a younger audience (like Newsbeat on BBC Radio 1), broadcast on NPO 3FM and NPO FunX. Since 2011 NOS op 3. NOS Radio 1 Journaal, a news and current affairs programme that is broadcast mornings and afternoons on NPO Radio 1. NOS Langs de lijn (Along the sideline), a sports programme on NPO Radio 1, featuring live sports coverage and results from the Eredivisie and other major sports. NOS Met het Oog op Morgen (With a view to tomorrow), a late-night current affairs programme on NPO Radio 1.
=== Metabolism === B. canis functions as a chemoorganotroph, deriving energy from the oxidation of organic compounds and utilizing organic electron sources. Studies indicate that B. canis, like other Brucella species, shares a conserved metabolic architecture within the genus. This includes a lack of phosphofructokinase (PFK), an enzyme required for the Embden–Meyerhof–Parnas (EMP) pathway (classical glycolysis). Instead, glucose catabolism is accomplished using the pentose phosphate pathway. While select Brucella species can also rely on a functional Entner–Doudoroff pathway, this pathway is not functional in most Brucella species, including B. canis, due to inactivating mutations. B. canis also possesses a complete tricarboxylic acid (TCA) cycle, which primarily utilizes oxygen as its terminal electron acceptor within its electron transport chain. In anaerobic conditions, nitrate can also function as a terminal electron acceptor because B. canis is capable of producing nitrate reductase. B. canis also exhibits strong urease activity, producing the enzyme urease to hydrolyze urea into ammonia and carbon dioxide. This enzymatic activity is relevant for its role in nitrogen acquisition and as a notable virulence factor, as it helps to neutralize and facilitate survival within surrounding acidic environments. For laboratory identification, a relevant metabolic characteristic of B. canis is that it does not require supplemental CO2 for growth, unlike some other Brucella species. Additionally, B.
=== Weather === American kestrels are often useful in scientific studies on animal physiology, and are typically captured using the bal-chatri method or raised in nest boxes for experiments. Kestrel metabolic rate has been found to increase in response to rainfall, and at ambient temperatures below about 25 °C. Kestrel metabolic responses to weather and temperature do not vary, however, with sex. Kestrels will increase their oxygen consumption, and therefore their metabolic rate in cold and wet conditions to counteract heat loss.
Sources: en.wikipedia.org
Iron-sulfur protein NUBPL (IND1) also known as nucleotide-binding protein-like (NUBPL), IND1 homolog, Nucleotide-binding protein-like or huInd1 is an iron-sulfur (Fe/S) protein that, in humans, is encoded by the NUBPL gene, located on chromosome 14q12. It has an early role in the assembly of the mitochondrial complex I assembly pathway. NUBPL is located on the q arm of chromosome 14 in position 12 and has 18 exons. The NUBPL gene produces a 5.9 kDa protein composed of 54 amino acids. The structure of the protein includes a presumed iron-sulfur binding (CxxC) signature, a nucleotide-binding domain which has been highly conserved, and a mitochondrial targeting sequence in the N-terminal. NUBPL is required for the assembly of complex I, which is composed of 45 evolutionally conserved core subunits, including both mitochondrial DNA and nuclear encoded subunits. One of its arms is embedded in the inner membrane of the mitochondria, and the other is embedded in the organelle. The two arms are arranged in an L-shaped configuration. The total molecular weight of the complex is 1MDa.
=== Physical properties === Technetium is a silvery-gray radioactive metal with an appearance similar to platinum, commonly obtained as a gray powder. The crystal structure of the bulk pure metal is hexagonal close-packed. Atomic technetium has characteristic emission lines at wavelengths of 363.3 nm, 403.1 nm, 426.2 nm, 429.7 nm, and 485.3 nm. The unit cell parameters of the orthorhombic Tc metal were reported when Tc is contaminated with carbon (a = 0.2805(4), b = 0.4958(8), c = 0.4474(5)·nm for Tc-C with 1.38 wt% C and a = 0.2815(4), b = 0.4963(8), c = 0.4482(5)·nm for Tc-C with 1.96 wt% C ). The metal form is slightly paramagnetic, meaning its magnetic dipoles align with external magnetic fields, but will assume random orientations once the field is removed. Pure, metallic, single-crystal technetium becomes a type-II superconductor at temperatures below 7.46 K (−265.69 °C; −446.24 °F). Below this temperature, technetium has a very high magnetic penetration depth, greater than any other element except niobium.
Phenylalkylpyrrolidines like PEP, MPEP, prolintane, α-PPP, α-PVP, pyrovalerone, and MDPV Phenylalkylpiperidines like AC927 (phenethylpiperidine), diphenidine, fentanyl, and ifenprodil Tetrahydroisoquinolines (THIQs) like anhalinine, pellotine, lophophorine, DOM-CR, nomifensine, tetrabenazine, and zelandopam Isoquinolines like perafensine, quinisocaine, and tilisolol Dihydroindoles and aminochromes like adrenochrome and adrenolutin 2-Aminoindanes (2-AIs) like 2-aminoindane, MDAI, MMAI, DOM-AI, and Pyr-AI 2-Aminotetralins (2-ATs) like 2-aminotetralin, MDAT, DOM-AT, 8-OH-DPAT, rotigotine, and UH-232 1-Aminomethylindanes (1-AMIs) like 2CB-Ind, AMMI, jimscaline, and bromojimscaline 3-Benzazepines like fenoldopam and lorcaserin Benzocyclobutenes (BCBs) like 2CBCB-NBOMe, S33005, TCB-2, tomscaline, and bromotomscaline 3-Aminochromans like CT-5126, 5-MeO-DPAC, robalzotan, and ebalzotan Benzoxepins like TFMBOX Phenylmethylpyrrolidines (benzylpyrrolidines) like APA-01 (PharmAla-1) 2-Benzylpiperidines and phenidates like 2-benzylpiperidine, methylphenidate, rimiterol, and DMBMPP Phenylcyclopropylamines like tranylcypromine, TMT, and DMCPA 3-Phenylpiperidines (3PIPs) like 3-phenylpiperidine, 3-PPP, OSU-6162 (PNU-96391), LPH-5, LPH-48, 2C-B-3PIP, 2C-B-3PIP-NBOMe, 2C-B-3PIP-POMe, and Z3517967757 (Z7757) 2-Phenylmorpholines like 2-phenylmorpholine, phenmetrazine, manifaxine, radafaxine, flumexadol, oxaflozane, and PF-219,061 Phenyloxazolamines or aminorex analogues like aminorex and pemoline Tricyclic compounds like benzoctamine and dizocilpine Ergolines and lysergamides like ergine (LSA) and LSD Partial ergolines and lysergamides like NDTDI, RU-27849, UCD0179, and UCD0120 Pyridopyrroloquinoxalines like lumateperone, IHCH-7113, IHCH-7086, and ITI-1549 Anthracenes like AMDA and SpAMDA Phenanthrenes like atherosperminine Aporphines like aporphine, apomorphine, glaucine, and nuciferine Others like 6-AB, 2-ADN, 2C-B-PYR, 2C-B-5-hemiFLY-α6 (BNAP), 2CB7 (2C-B-5-hemiFLY-β7), 2CBecca, 2CJP, 2CLisaB, 2CLisaH, 2-naphthylamine, AMMI, GYKI-52895, ivabradine, milnacipran, Org 6582, and ZC-B Some additional cyclized phenethylamines have also been described. Other related families that are not phenethylamines themselves include phenylpiperazines, benzylpiperazines, and 4-phenylpiperidines.
== Recalls == In 2018–2019, Teva Pharmaceuticals USA recalled antihypertensive tablets containing valsartan and losartan due to the detection beyond acceptable limit of N-nitrosodiethylamine (NDEA) and N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), respectively, which are probable human carcinogens.
Data regarding short- and long-term complications is included in the IUGA's recommendations to assess the procedure's risk–benefit ratio more effectively. Current investigations into the superiority of using biological grafting versus native tissue or surgical mesh indicate that grafting provides better results.
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.